MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pfizer CT.gov Call Center
Pfizer
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St Vincent'S Hospital (melbourne)
Fitzroy, Victoria, Australia
- the Alfred
Melbourne, Victoria, Australia
- Epworth Healthcare
Richmond, Victoria, Australia
- Ciusss-Emtl, Installation Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Mcgill University Health Centre - Glen Site
Montreal, Quebec, Canada
- Chu de Lille - Hopital Claude Huriez
Lille, France
- Chu de Nantes - Hôtel Dieu
Nantes, France
- Centre Hospitalier Lyon Sud - Service D'Hematologie Clinique
Pierre-Bénite, France
- Chu de Poitiers, Pôle Régional de Cancérologie
Poitiers, France
- Universitätsklinikum Hamburg - Eppendorf
Hamburg, Germany
- Nagoya City University Hospital
Nagoya, Aichi-ken, Japan
- Gunma University Hospital
Maebashi, Gunma, Japan
- Kobe City Medical Center General Hospital
Kobe, Hyōgo, Japan
- Tohoku University Hospital
Sendai, Miyagi, Japan
- Szpital Uniwersytecki Nr 2 Im. Dr Jana Biziela W Bydgoszczy
Bydgoszcz, Poland
- Szpital Kliniczny Im. Heliodora Święcickiego Um W Poznaniu
Poznan, Poland
- Clinica Universitaria de Navarra
Madrid, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario Doctor Peset
Valencia, Spain
- Beverly Hills Cancer Center
Beverly Hills, California, United States
- Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Ucla Hematology/oncology Clinic
Los Angeles, California, United States
- Uc Irvine Health - Chao Family Comprehensive Cancer Center
Orange, California, United States
- Baptist Hospital of Miami
Miami, Florida, United States
- Miami Cancer Institute
Miami, Florida, United States
- Blood and Marrow Transplant Group of Georgia
Atlanta, Georgia, United States
- Emory University
Atlanta, Georgia, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- Northwestern Medical Group
Chicago, Illinois, United States
- Northwestern Memorial Hospital
Chicago, Illinois, United States
- Loyola University Chicago Performing Research at Loyola University Medical Center
Maywood, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Norton Women'S and Children'S Hospital
Louisville, Kentucky, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Regional Cancer Care Associates, Llc
Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy
Long Island City, New York, United States
- Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York, United States
- Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York, United States
- St Francis Physician Services Inc
Greenville, South Carolina, United States
- Baylor Scott & White Research Institute
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Feb 2021
- Primary completion
- 17 Jun 2022
- Completion
- 31 Dec 2026
- Last update posted
- 19 May 2026
- Registered enrollment
- 187
- Registry id
- NCT04649359
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.